Royalty Financing Agreement - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended
	Oct. 31, 2022	Sep. 01, 2025	Sep. 30, 2024	Dec. 31, 2023	Oct. 01, 2022
Debt Instrument [Line Items]
Royalty financing liability			$ 6,639	$ 5,674
Royalty Agreements
Debt Instrument [Line Items]
Royalty financing liability			$ 3,700	$ 3,300
Royalty Agreements | Minimum
Debt Instrument [Line Items]
Royalty maximum	1.8
Royalty Agreements | Maximum
Debt Instrument [Line Items]
Royalty maximum	1.9
Royalty Agreements | ARIKAYCE Global Net Sales
Debt Instrument [Line Items]
Royalty percentage					4.00%
Royalty Agreements | ARIKAYCE Global Net Sales | Forecast
Debt Instrument [Line Items]
Royalty percentage		4.50%
Royalty Agreements | Brensocatib Global Net Sales
Debt Instrument [Line Items]
Royalty percentage	75.00%
Secured Debt | Royalty Agreements
Debt Instrument [Line Items]
Proceeds from royalty financing	$ 150,000
Face amount	150,000
Interest payments	150,000
Lenders fees and deal expenses	3,800
Proceeds from royalty financing agreement, net	$ 146,200
Effective interest rate	12.40%